News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
698,349 Results
Type
Article (41501)
Company Profile (460)
Press Release (656388)
Section
Business (208344)
Career Advice (1999)
Deals (35935)
Drug Delivery (90)
Drug Development (83262)
Employer Resources (169)
FDA (16322)
Job Trends (15037)
News (351989)
Policy (32972)
Tag
Academia (2619)
Alliances (50557)
Alzheimer's disease (1253)
Approvals (16234)
Artificial intelligence (121)
Bankruptcy (361)
Best Places to Work (11654)
Biotechnology (345)
Breast cancer (104)
Cancer (906)
Career advice (1670)
Cell therapy (205)
Clinical research (65621)
Collaboration (334)
Compensation (157)
COVID-19 (2580)
Cystic fibrosis (82)
Data (839)
Diabetes (130)
Diagnostics (6147)
Drug pricing (83)
Earnings (85276)
Employer resources (146)
Events (112160)
Executive appointments (243)
FDA (16751)
Funding (294)
Gene therapy (161)
GLP-1 (587)
Government (4401)
Healthcare (18972)
Infectious disease (2652)
Inflammatory bowel disease (107)
Interviews (308)
IPO (16539)
Job creations (3693)
Job search strategy (1427)
Layoffs (434)
Legal (7922)
Lung cancer (157)
Manufacturing (149)
Medical device (13284)
Medtech (13289)
Mergers & acquisitions (19389)
Metabolic disorders (368)
Neuroscience (1501)
NextGen Class of 2024 (6727)
Non-profit (4530)
Northern California (1178)
Obesity (220)
Opinion (194)
Patents (94)
People (57451)
Pharmaceutical (86)
Phase I (20538)
Phase II (28952)
Phase III (21449)
Pipeline (202)
Postmarket research (2590)
Preclinical (8811)
Radiopharmaceuticals (250)
Rare diseases (192)
Real estate (5996)
Regulatory (21859)
Research institute (2402)
Resumes & cover letters (351)
Southern California (1070)
Startups (3745)
United States (11721)
Vaccines (549)
Weight loss (169)
Date
Today (180)
Last 7 days (852)
Last 30 days (2993)
Last 365 days (37078)
2024 (30923)
2023 (41013)
2022 (52276)
2021 (56765)
2020 (54924)
2019 (47419)
2018 (35697)
2017 (33025)
2016 (32346)
2015 (38396)
2014 (32185)
2013 (27109)
2012 (29220)
2011 (29863)
2010 (27992)
Location
Africa (731)
Arizona (194)
Asia (38380)
Australia (6378)
California (2727)
Canada (1159)
China (208)
Colorado (116)
Connecticut (124)
Europe (83657)
Florida (381)
Georgia (96)
Illinois (318)
Indiana (178)
Kansas (98)
Maryland (518)
Massachusetts (2253)
Michigan (144)
Minnesota (252)
New Jersey (817)
New York (829)
North Carolina (712)
Northern California (1178)
Ohio (124)
Pennsylvania (741)
South America (1105)
Southern California (1070)
Texas (380)
Washington State (327)
698,349 Results for "teon therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Business
Teon Therapeutics Announces Clinical Trial Collaboration With Merck to Evaluate TT-816, a Novel Oral Immune Response Modifier, in Combination with KEYTRUDA® (pembrolizumab)
Teon Therapeutics today announced that it has entered into the clinical trial collaboration agreement with Merck (known as MSD outside the United States and Canada), a leader in immuno-oncology (IO).
January 18, 2023
·
5 min read
Press Releases
Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)
October 8, 2024
·
14 min read
Business
Gain Therapeutics, Inc. Appoints Gene Mack as Interim CEO
Gain Therapeutics, Inc. announces that Matthias Alder has departed the Company in order to pursue other opportunities.
June 27, 2024
·
5 min read
Press Releases
ReCerise Therapeutics Inc. Selected for Government Project by MOTIE
Initiates Development of Tailored Innovative Targeted Therapy for Refractory Cancer ReCerise Therapeutics Inc., has announced its selection for a grant from the Ministry of Trade, Industry and Energy of South Korea.
July 1, 2024
·
2 min read
Pharm Country
Click Therapeutics Accelerates Expansion into Obesity and Cardiometabolic Disease With Acquisition of the Assets of Better Therapeutics, Inc.
Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced plans to accelerate its development initiatives in obesity and cardiometabolic disease through the acquisition of the assets of Better Therapeutics, Inc.
May 22, 2024
·
7 min read
Press Releases
Acasti Announces Corporate Name Change to Grace Therapeutics, Inc.
October 28, 2024
·
8 min read
Press Releases
ME Therapeutics Holdings Inc. Appoints Chief Business Officer
October 25, 2024
·
4 min read
Biotech Bay
Teon Therapeutics Announces FDA Acceptance of IND Application for Novel, Oral Immune Checkpoint Inhibitor, TT-816
Teon Therapeutics Announces FDA Acceptance of IND Application for Novel, Oral Immune Checkpoint Inhibitor, TT-816.
June 1, 2022
·
5 min read
Press Releases
Monopar Therapeutics Inc. Announces Proposed Public Offering of Common Stock
October 29, 2024
·
4 min read
1 of 69,835
Next
